WHO reports two cases of the deadly virus were confirmed near the border with Uganda.
Two of the first 10 people to receive an experimental Ebola treatment have recovered from the highly dangerous disease.
Four more experimental treatments for Ebola virus have been approved by the Congo health ministry for use in an outbreak of the deadly infectious disease in the country's northeast.
First to be vaccinated will be health workers, contacts of confirmed Ebola patients
The number of confirmed cases in a new Ebola outbreak in Congo has reached 13, including three deaths.
Just a week after being declared Ebola-free, the DRC said that a new outbreak of the deadly virus has killed at least 20 people.
Outbreak report describes transmission of Ebola virus one year after survival of Ebola virus disease.
The latest Ebola outbreak in the Democratic Republic of Congo is over according to the WHO.
Survivors of Ebola virus disease have localized pathological changes in photoreceptors.
Study provides new data on the durability of the humoral immune response up to 2 years after single-dose injection with rVSV-ZEBOV vaccine in a population of primarily European ancestry, and additional data on durability at 1 year after vaccination in 2 African populations.
First-hand accounts of the care that was delivered during the 2013-16 West African outbreak of Ebola virus disease provided impetus for these guidelines.
Two vaccines to prevent Ebola virus disease demonstrated immune responses at 1 month.
A new research letter claims that 27 viruses can be found in human semen.
An Ebola virus vaccine, rVSVΔG-ZEBOV-GP, provided 100% protection against Ebola in a prior phase 3 trial. A new study reports long-term safety data and shows that the vaccine induces an antibody response for at least 1 year.
A small percentage of Ebola virus survivors have a novel retinal lesion as a result of the disease.
The number of suspected Ebola cases in the Democratic Republic of Congo has risen to 37.
Researchers discuss a case of an Ebola virus disease survivor with HIV coinfection whose semen tested positive for Ebola virus RNA 565 days after recovering from the disease.
A strategy of preemptive use of an AD26.ZEBOV followed by MVA-BN-Filo immunization schedule in at-risk populations may offer advantages over reactive use of single-dose vaccine regimens.
Changes in messenger RNA abundance proved to be a reliable means of predicting patient's chances of surviving Ebola virus disease.
A new vaccine for Ebola showed high efficacy in preventing the development of Ebola in clusters of people exposed to the virus, and protection was also conferred to those who were not vaccinated.
Liberia's Men's Health Screening Program for Ebola survivors successful in spite of complex challenges.
Virus is more likely to be found in male survivors older than 40, researchers report.
The FDA's Breakthrough Therapy Designation is intended to expedite the development and review of a candidate vaccine that is planned for use, alone or in combination, to treat a serious or life-threatening disease or condition.
CDC activated its Emergency Operations Center (EOC) for the Ebola response on July 9, 2014.
The CDC releases infection control measures implemented at a Texas hospital.
Approximately one-fifth developed severe or total vision loss within weeks of recovery.
Antibody is cost-effective, reducing economic burden that may result from this dangerous virus.
One vaccine provided first as a primer, and the second given as a booster.
Six months after active illness, headaches, memory loss, depression were still being reported.
Two vaccine candidates are well-tolerated and immunogenic in adult volunteers.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- The Misuse of Antibiotics in Acute Pancreatitis Appears Widespread
- Polio-Like Condition in Children on Rise in the United States
- Pneumococcal H Influenzae Protein D Conjugate Vaccine Effective in Children
- Mental Health Problems in Adolescents With HIV: Overview & Expert Interview
- Severity of Acute Respiratory Infections in Children Affected by Viral Etiology
- Antibiotic Prophylaxis Before Dental Procedures May Be Unnecessary
- Penicillin Allergies: Commonly Reported but Rarely Accurate
- Irritable Bowel Syndrome Treatments
- Oral Ciprofloxacin Effective in Treatment for Bacteremia
- Need for Adequate Screening for Infants With HCV Infected Mothers During Pregnancy
- Identifying Spatial Clusters of HIV-Hepatitis Co-Infection to Effectively Target Intervention Programs
- Epidemiology of K pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children
- Social Support Important in Short-Term Care for Older Adults With HIV
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Low-Dose Methotrexate: No Effect on Endothelial Function in Patients Treated for HIV